Kevin Punie, MD, discusses PRO data from the phase 3 ASCENT-03 trial.
Kevin Punie, MD, PhD
Advertisement
Kevin Punie, MD, PhD, is a medical oncologist working as a staff member at the department of General Medical Oncology in the University Hospitals Leuven.
Articles by Kevin Punie, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5